Curaleaf Holdings Inc. (TO:CURA) — Market Cap & Net Worth
Market Cap & Net Worth: Curaleaf Holdings Inc. (CURA)
Curaleaf Holdings Inc. (TO:CURA) has a market capitalization of $2.52 Billion (CA$3.49 Billion) as of September 19, 2026. Listed on the TO stock exchange, this Canada-based company holds position #5434 globally and #186 in its home market, demonstrating a 1.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curaleaf Holdings Inc.'s stock price CA$14.37 by its total outstanding shares 672456187 (672.46 Million). Also see Curaleaf Holdings Inc. (CURA) total assets for a full breakdown of the balance sheet.
Curaleaf Holdings Inc. Market Cap History: 2021 to 2026
Curaleaf Holdings Inc.'s market capitalization history from 2021 to 2026. Data shows change from $5.50 Billion to $7.13 Billion (-4.64% CAGR). Also see CURA cash flow conversion for how efficiently the company converts equity into cash flow.
Curaleaf Holdings Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curaleaf Holdings Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Curaleaf Holdings Inc. share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.81x
Curaleaf Holdings Inc.'s market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $5.50 Billion | $1.21 Billion | -$109.13 Million | 4.54x | N/A |
| 2022 | $2.84 Billion | $1.34 Billion | -$376.93 Million | 2.12x | N/A |
| 2023 | $2.68 Billion | $1.35 Billion | -$281.20 Million | 1.99x | N/A |
| 2024 | $1.09 Billion | $1.34 Billion | -$215.42 Million | 0.81x | N/A |
Competitor Companies of CURA by Market Capitalization
Companies near Curaleaf Holdings Inc. in the global market cap rankings as of September 19, 2026. Review tangible net worth ratio of Curaleaf Holdings Inc. to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Curaleaf Holdings Inc. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #619 globally with a market cap of $44.48 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #637 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Haleon plc (NYSE:HLN): Ranked #665 globally with a market cap of $41.22 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #520 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #619 | GALDERMA GROUP AG | NYSE:GALDY | $44.48 Billion | $38.15 |
| #637 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.10 |
| #665 | Haleon plc | NYSE:HLN | $41.22 Billion | $9.36 |
Curaleaf Holdings Inc. Historical Marketcap From 2021 to 2026
Between 2021 and today, Curaleaf Holdings Inc.'s market cap moved from $5.50 Billion to $ 7.13 Billion, with a yearly change of -4.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$7.13 Billion | +329.91% |
| 2025 | CA$1.66 Billion | +52.23% |
| 2024 | CA$1.09 Billion | -59.35% |
| 2023 | CA$2.68 Billion | -5.49% |
| 2022 | CA$2.84 Billion | -48.41% |
| 2021 | CA$5.50 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Curaleaf Holdings Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.52 Billion USD |
| MoneyControl | $2.52 Billion USD |
| MarketWatch | $2.52 Billion USD |
| marketcap.company | $2.52 Billion USD |
| Reuters | $2.52 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Curaleaf Holdings Inc.
Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinct… Read more